Follow
Qing (Amanda) Z.
Qing (Amanda) Z.
Statistician
Verified email at merck.com
Title
Cited by
Cited by
Year
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O Hamid, C Robert, A Daud, FS Hodi, WJ Hwu, R Kefford, JD Wolchok, ...
Annals of Oncology 30 (4), 582-588, 2019
7792019
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ...
Nature medicine 25 (3), 454-461, 2019
5422019
Strategies for dealing with missing data in clinical trials: from design to analysis
JD Dziura, LA Post, Q Zhao, Z Fu, P Peduzzi
The Yale journal of biology and medicine 86 (3), 343, 2013
3942013
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
A Ribas, D Lawrence, V Atkinson, S Agarwal, WH Miller Jr, MS Carlino, ...
Nature medicine 25 (6), 936-940, 2019
3052019
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA
Q Zhao, X Shi, Y Xie, J Huang, BC Shia, S Ma
Briefings in bioinformatics 16 (2), 291-303, 2015
1452015
Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma
D Davar, H Wang, JM Chauvin, O Pagliano, JJ Fourcade, M Ka, C Menna, ...
Journal of Clinical Oncology 36 (35), 3450, 2018
662018
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis
Y Jiang, X Shi, Q Zhao, M Krauthammer, BEG Rothberg, S Ma
Genomics 107 (6), 223-230, 2016
552016
Integrative analysis of ‘‐omics’ data using penalty functions
Q Zhao, X Shi, J Huang, J Liu, Y Li, S Ma
Wiley Interdisciplinary Reviews: Computational Statistics 7 (1), 99-108, 2015
402015
Transcriptomic determinants of response to pembrolizumab monotherapy across solid tumor types
R Cristescu, M Nebozhyn, C Zhang, A Albright, J Kobie, L Huang, Q Zhao, ...
Clinical Cancer Research 28 (8), 1680-1689, 2022
372022
Integrating multidimensional omics data for cancer outcome
R Zhu, Q Zhao, H Zhao, S Ma
Biostatistics 17 (4), 605-618, 2016
362016
Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach
X Shi, Q Zhao, J Huang, Y Xie, S Ma
Bioinformatics (2015), btv518, 2015
322015
Tumor mutational burden (TMB), T cell-inflamed gene expression profile (GEP) and PD-L1 are independently associated with response to pembrolizumab (Pembro) in patients with …
A Ribas, C Robert, J Schachter, GV Long, A Arance, MS Carlino, J Larkin, ...
Cancer Research 79 (13_Supplement), 4217-4217, 2019
182019
Analysis of cancer gene expression data with an assisted robust marker identification approach
H Chai, X Shi, Q Zhang, Q Zhao, Y Huang, S Ma
Genetic epidemiology 41 (8), 779-789, 2017
172017
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study
IM Shui, XQ Liu, Q Zhao, ST Kim, Y Sun, JH Yearley, T Choudhury, ...
Journal for Immunotherapy of Cancer 10 (7), 2022
142022
Inferring gene regulatory relationships with a high‐dimensional robust approach
Y Zang, Q Zhao, Q Zhang, Y Li, S Zhang, S Ma
Genetic epidemiology 41 (5), 437-454, 2017
132017
Association of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427.
DF McDermott, JL Lee, F Donskov, SS Tykodi, GA Bjarnason, JMG Larkin, ...
Journal of Clinical Oncology 38 (15_suppl), 5024-5024, 2020
92020
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms
NC Gunawardana, Q Zhao, LN Carayannopoulos, K Tsai, VA Malkov, ...
Journal of Allergy and Clinical Immunology 141 (2), 785-788. e9, 2018
92018
Pan-tumor analysis of the association of cancer and immune biology-related gene expression signatures with response to pembrolizumab monotherapy
R Cristescu, M Nebozhyn, C Zhang, A Albright, J Kobie, L Huang, Q Zhao, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
42019
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome
H Wang, S Tian, Q Zhao, W Blumenschein, JH Yearley, CR Secreto, ...
Hematological oncology 40 (2), 302-306, 2022
12022
Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib
H Wang, S Tian, Q Zhao, W Blumenschein, JH Yearley, CR Secreto, ...
Blood 136, 30-31, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20